|
|
| 1.28 Data as of Mar 10 |  0.00 / 0.00%Today’s Change | 0.99 Today|||52-Week Range 2.58 | -7.25% Year-to-Date |
| Previous close | 1.28 |
| Today’s open | 1.28 |
| Day’s range | 1.25 - 1.29 |
| Volume | 696,832 |
| Average volume (3 months) | 1,923,616 |
| Market cap | $72.1M |
| Dividend yield | -- |
| Earnings growth (last year) | +40.80% |
| Earnings growth (this year) | +140.13% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -6.62% |
| P/E ratio | -- |
| Price/Sales | 1.40 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| CDXSCodexis Inc | 0.00 | 0.00% |
| IMUCImmunoCellular Thera... | -0.03 | -2.24% |
| PBMDPrima BioMed Ltd | 0.00 | 0.00% |
| ENMDEntreMed Inc | -0.03 | -1.64% |
| Next reporting date | March 25, 2014 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $33.7M |
| Annual profit (last year) | -$20.4M |
| Net profit margin | -60.63% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director David A. Dodd |
Chief Financial Officer & Senior Vice President Dennis Turpin |
Corporate headquarters Québec, Quebec |
.
